In the BioHarmony Drug Report Database

"Preview" Icon

Cabotegravir

Vocabria (cabotegravir) is a small molecule pharmaceutical. Cabotegravir was first approved as Vocabria on 2020-12-17. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Cabenuva’s patent is valid until 2026-04-28 (FDA).

 

Trade Name

 

Vocabria
 

Common Name

 

cabotegravir
 

ChEMBL ID

 

CHEMBL2403238
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals: integrase inhibitors

Image (chem structure or protein)

Cabotegravir structure rendering